{
    "code": "02007088",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02007088",
    "time": "2016-11-18 17:24:52",
    "許可證字號": "衛署藥輸字第007088號",
    "註銷狀態": "已註銷",
    "註銷日期": "74\/10\/02",
    "註銷理由": "移轉（申請商）",
    "有效日期": "76\/04\/19",
    "發證日期": "69\/04\/19",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00200708803",
    "中文品名": "解礙顆粒",
    "英文品名": "SHINLACTAN FINE GRANULES",
    "適應症": "下記腦血流障礙之改善：腦中風（腦出血、腦血栓、腦塞栓）腦動脈硬化症、高血壓性腦循環不全、頭部外傷後遺症",
    "劑型": "150內服顆粒劑",
    "包裝": "罐裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "CINNARIZINE"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "0811701100  武聖行有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F260330000  TAKESHIMA PHARMACEUTICAL CO., LTD.",
        "製造廠廠址": "7-5 MINAMISAKAE-CHO, KASUKABE, SAITAMA-KEN.7-11, 4-CHOME, KOMAGOME, TOSHIMA-KU,TOKYO 170,JAPAN.",
        "製造廠公司地址": "7-11, 4-CHOME, KOMAGOME, TOSHIMA-KU,TOKYO 170,JAPAN.",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0400000900",
            "成分名稱": "CINNARIZINE",
            "含量描述": "100",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ]
}